⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25319073 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL19897209 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL19897343 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL25322783 | 0.75 | ALDH1A1 (0.35) | — | |
| SCHEMBL3232762 | 0.74 | POLB (0.32) | — | |
| SCHEMBL16147311 | 0.73 | HTT (0.36) | — | |
| SCHEMBL3659312 | 0.73 | — | — | |
| SCHEMBL22636192 | 0.71 | ACE (0.34) | — | |
| SCHEMBL22371728 | 0.69 | — | — | |
| SCHEMBL5167480 | 0.68 | RECQL (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12377070-B2 | Substituted sulfoximine derivatives | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-08-05 | — | — | US | disclosed |
| US-20220313657-A1 | NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES | CADILA HEALTHCARE LIMITED (IN) | 2022-10-06 | — | — | US | disclosed |
| US-9856238-B2 | 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders | SUNOVION PHARMACEUTICALS INC. (US) | 2018-01-02 | — | — | US | disclosed |
| US-20170001987-A1 | 1-HETEROCYCLYL ISOCHROMANYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS | SUMITOMO PHARMA AMERICA, INC. | 2017-01-05 | — | — | US | disclosed |
| US-20130296311-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2013-11-07 | — | — | US | disclosed |
| EP-2575866-A1 | INHIBITORS OF HCV NS5A | Presidio Pharmaceuticals, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2575475-A1 | INHIBITORS OF HCV NS5A | Presidio Pharmaceuticals, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011150243-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011149856-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |